_erythroid-and-megakaryoblastic-leukemia-from-models-to-targeted-therapy-preview-1.jpg "Erythroid and Megakaryoblastic Leukemia; from Models to Targeted Therapy from erythroid Video Screenshot Preview 1")
Gallery_erythroid-and-megakaryoblastic-leukemia-from-models-to-targeted-therapy-preview-3.jpg "Erythroid and Megakaryoblastic Leukemia; from Models to Targeted Therapy from erythroid Video Screenshot Preview 3")
Gallery_erythroid-and-megakaryoblastic-leukemia-from-models-to-targeted-therapy-preview-hqdefault.jpg "Erythroid and Megakaryoblastic Leukemia; from Models to Targeted Therapy from erythroid Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 54 minutes 20 seconds
👁 View: 342 times
Play Audio:👁 View: 342 times
Description:
UW Video
UW Video
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_participant-1-prof-lucia-altucci-md-phd.webp "Participant 1: Prof. Lucia ALTUCCI, MD, PhDnnDepartment of General Pathology, Seconda Università degli Studi di Napoli, ItalynDescription of the contribution to the projectnnCO1 group will evaluate the settings of global LChIP and sorting LChIP (WP1, 3, 4). Dynamic chromatin regulations in terms of TFs occupancies (Sps, MYC family etc), phosphorylation, acetylation and methylation, will be globally analysed. LChIP and global LChIP studies will be performed to compare XChIP with the LChIP techno")
_evaluating-erythroid-precursors-in-patients-with-lr-mds-to-predict-response-to-esas.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 49 seconds 👁 31
_pure-erythroid-leukaemias.webp "Dr Montalbán Bravo meets with ecancertv at ASH 2016 to discuss the aetiology and prognostic outlook of pure erythroid leukaemia, a subset of acute leukaemia.nnHe discusses the cell lineage of the disease, and describes sequencing data helping to form a greater genetic and biological understanding of PEL and its treatment choices.nnDr Montalbán Bravo also spoke with ecancer about the clinical utility of guadecitabine and azacitadine plus verinostat.")
_morphology-of-erythroid-cells.webp "Blood and Hematology")
_pure-erythroid-leukaemias.webp "ecancer")
_single-cell-profiling-reveals-key-differences-in-architecture-of-stem-and-progenitor-cells-throughout-life.webp "Dr Roy speaks with ecancer at EHA 23 about observed changes in blood stem cells over at different stages of development, from infancy to adulthood.nnShe describes how, starting from matched liver and bone marrow samples, changes in erythroid, myeloid and lymphoid progenitor cell populations can be charted, and differences between samples indicate a driver of differentiation in the microenvironment.")
⏲ 3 min 78 sec ✓ 16-Jun-2018
_participant-1-prof-lucia-altucci-md-phd.jpg)
_evaluating-erythroid-precursors-in-patients-with-lr-mds-to-predict-response-to-esas.jpg)
_pure-erythroid-leukaemias.jpg)
_morphology-of-erythroid-cells.jpg)
_pure-erythroid-leukaemias.jpg)
_single-cell-profiling-reveals-key-differences-in-architecture-of-stem-and-progenitor-cells-throughout-life.jpg)
![[+]](/images/menu.gif){kind=small}